Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

First Three-Parent Baby Born As A Result Of New Fertility Technique

XTALKS VITALS NEWS

Embryo

If the promising results from the animal studies can be reproduced in humans, the blood vessel grafts could reduce the number of surgeries needed to correct congenital heart defects in children.

Tweetables from this article:

Tweet: New technique will allow parents with rare mitochondrial mutations to have healthy children #mitochondrialdisease http://ctt.ec/k3437+New technique will allow parents with rare mitochondrial mutations to have healthy children.

Share this!

September 29, 2016 | by Sarah Hand, M.Sc.

Using a new technique which combines the genetic material from three people, a baby boy with three biological parents has been born. Now five-months-old, the boy carries DNA from his mother, his father and a third egg donor.

The groundbreaking technique will allow parents with rare mitochondrial mutations to have healthy children. While the technique is currently only approved in the UK, embryologists say the birth of this child will spur more approvals around the world.

The mother of the child carries a mutation for a fatal nervous system disorder known as Leigh syndrome in her mitochondrial DNA. As mitochondrial DNA is passed down through the maternal line, any naturally-conceived children could inherit the life-threatening mutation.

Approximately 25 percent of her mitochondria contain the gene for Leigh syndrome, however the disorder does not affect her. After her first two children died as a result of the disorder, the Jordanian couple sought the help of New York City-based fertility specialist, Dr. John Zhang of the New Hope Fertility Center.

In order to prevent the mitochondrial disease, Zhang and his colleagues have been developing various three-parent techniques. Pronuclear transfer – the method that is currently approved in the UK – involves fertilizing the mother’s egg and a donor egg with sperm collected from the father. Each nucleus is removed from the fertilized eggs before they move into early-stage embryos, and the nucleus from the mother’s fertilized egg is used to replace that taken from the donor’s embryo.



In this case, since two embryos are destroyed in the pronuclear transfer process, it was an inappropriate procedure for the Muslim parents. Instead, Zhang removed the nucleus from a donor egg and replaced it with the nucleus from the mother’s egg before fertilization. In a process known as spindle nuclear transfer, the resulting egg was fertilized with the father’s sperm.

Since the technique is not currently approved in the US, Zhang and his team travelled to Mexico to complete the procedure. According to Zhang, his decision to use the three parent technique was the right one. “To save lives is the ethical thing to do,” said Zhang.

The boy is showing no signs of Leigh syndrome and less than one percent of his mitochondria were found to carry the disease-causing mutation. Zhang is hopeful that this will be too few copies of the mutation to cause symptoms, as 18 percent of mitochondria must carry the gene before the disease manifests itself.

While this technique appears to be safe so far, reproductive medicine has had a less-than-perfect track record when it comes to experimental procedures. In the 1990s, a three-person technique – whereby mitochondrial DNA from a donor was injected into a fertilized egg – resulted in babies with genetic disorders. While the technique was eventually banned, some believe that the problems were a result of the babies’ cells containing two sets of genetically-distinct mitochondria.


Keywords: Mitochondrial DNA, Mutation, Fertility


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New Approach Could Allow Red Blood Cells to be Manufactured

March 27, 2017 - UK researchers at the University of Bristol have developed an immortal line of early adult erythroblasts capable of continuously producing mature red blood cells.

Featured In: Biotech News


Lung Cancer Recurrence Could Be Better Detected Using Biomarker Blood Test

March 24, 2017 - The results of a recent prospective clinical trial found that a biomarker blood test could detect lung cancer recurrence a full six months before imaging methods could spot the disease.

Featured In: Biotech News


Use of Testosterone Treatments Boosted by DTC Ad Campaigns

March 24, 2017 - Those with a stake in the pharmaceutical industry often question the effectiveness of direct-to-consumer (DTC) advertising, and whether it truly influences consumers to talk to their doctors about medical conditions and perhaps even ask for drugs by name.

Featured In: Pharmaceutical Marketing News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.